Views: 0 Author: Site Editor Publish Time: 2026-09-30 Origin: Site
A needle coating line may run at a steady speed, but the silicone oil working solution may not remain the same throughout the shift. Dilution, solvent evaporation, replenishment and mixing can all change its concentration. When those changes are not measured, manufacturers may find that needles made at different times show different coating and insertion-force results.
For medical needle manufacturers, the question is therefore broader than which silicone oil to purchase. The formulation, preparation method, coating equipment and inspection plan must work together. This guide explains where concentration changes can occur, how to evaluate their effect and what to ask before scaling a coating process.
A stable machine setting does not necessarily mean a stable silicone oil working concentration.
Concentration should be measured using a defined method and sampling plan suited to the formulation.
Coating results must be checked on finished needles under a consistent test protocol.
Needle gauge, bevel geometry and intended use affect how a formulation should be evaluated.
Formulation selection and equipment assessment should be considered together when coating results vary.
Silicone oil is applied to medical needles to support the required surface and insertion performance. Manufacturers may receive a concentrated formulation and prepare a working solution before it enters the siliconization equipment. The concentration at preparation is only the starting point.
During production, a solvent-containing working solution may change as solvent evaporates. Adding fresh solution, changes in bath volume and insufficient mixing may introduce further variation. The extent of those changes depends on the formulation, equipment design and operating conditions.
This variation matters because the coating process must deliver consistent results over an entire production run. A sample taken at startup may perform differently from one taken hours later. Without concentration records and finished-needle test data, it can be difficult to determine whether a change came from the material, the process or the needle itself.
Concentration is a useful control parameter, but it is not a complete measure of coating quality. Manufacturers should evaluate it alongside application conditions and test results from finished needles.
Document the selected formulation, diluent, dilution ratio and mixing procedure. Operators should follow the same preparation steps for each batch and record when the solution is made or replenished. Storage and handling conditions should also follow the instructions for the specific material.
Choose a measurement method appropriate for the formulation and agree on where and when samples will be taken. Useful sampling points may include startup, scheduled intervals during production and after replenishment. The acceptable working range should be established through trials on the actual production process; there is no single concentration target suitable for every needle and silicone oil formulation.
Review how the siliconization station applies the solution to the needle. Application geometry, exposure time, mixing or circulation, and drying or curing conditions where applicable may all affect the final coating. If concentration is controlled but finished-needle results remain inconsistent, the equipment and application process need closer examination.
Test needles produced at different points in the run using the same method. Record the needle specification, test medium, insertion speed, sample size and results. Comparing startup, mid-run and end-of-run samples can help the team see whether process changes correspond to changes in performance.
An AVF needle, an insulin pen needle and a blood collection needle do not present identical coating requirements. Their gauges, tip designs and intended uses differ, so a formulation that works well in one evaluation cannot simply be assumed suitable for another.
Needle Type | Coating Requirement | Suggested Evaluation |
AVF needles, including 16G | Manage penetration force for larger-gauge needles. | Compare one-step and two-step coating options using the customer’s needle geometry. |
Insulin pen needles, 31G to 34G | Assess coating retention after repeated penetration. | Test penetration force across a defined series of punctures. |
Blood collection needles, 18G to 30G | Support low initial penetration force and compatibility with high-volume assembly. | Measure initial penetration force and review coating process stability. |
The comparison should use the customer’s own needle samples wherever possible. Needle geometry and test conditions should remain consistent so that changes in the coating approach can be evaluated clearly.
A manufacturer may try a new silicone oil because insertion-force results vary. Yet the cause may also involve how the solution is prepared, measured or applied. Likewise, equipment adjustments alone may not address a formulation that does not suit the needle’s application.
A practical development process begins by defining the target and reviewing the current line. The team can then prepare coated samples, compare their test results and assess whether the existing siliconization equipment can maintain the selected process. Where it cannot, an equipment modification may be considered based on the trial findings.
TOPKEY supports application-specific silicone oil formulation discussions as well as dilution guidance, concentration measurement and assessment of the coating process. The proposed approach depends on the customer’s needle and production conditions.
When introducing or adjusting an automated needle coating process, watch for these issues:
Testing only at startup. A good initial result does not show what happens after several hours of operation.
Changing multiple variables at once. Adjusting the formulation, dilution ratio and machine settings together makes the results harder to interpret.
Using an undefined sampling method. Samples taken from different locations or at inconsistent times may not be comparable.
Comparing different needle geometries. Changes in gauge or bevel design can affect insertion-force results independently of the coating.
Scaling before confirming the process. A small sample trial should be followed by a production-representative evaluation before routine use.
Consistent needle coating starts with a controlled process. Measuring silicone oil concentration during production helps manufacturers understand changes in the working solution, while finished-needle testing shows whether the process is delivering the intended result.
TOPKEY works with medical needle manufacturers on formulation selection, sample evaluation and siliconization process support. If you are developing a new needle or investigating inconsistent coating results, share your needle specifications, current process and test method with our team. We can discuss an evaluation plan based on your production needs.
Not necessarily. In a solvent-containing working solution, evaporation and replenishment may change the concentration. The actual effect should be measured under the line’s operating conditions.
No. The appropriate working range depends on the formulation, needle and coating process. It should be established through controlled trials and finished-needle testing.
The two provide different information. Concentration measurement helps monitor the working solution; insertion-force testing evaluates the finished needle under a defined method. Used together, they give a clearer picture of the process.
Please provide the needle type, gauge, tip or bevel drawing, intended use, current coating method and equipment information. If available, include uncoated needle samples and your existing insertion-force test protocol.
It may be possible, but compatibility should be checked through a process review and trial. If the station cannot maintain the required application conditions, TOPKEY can discuss suitable adjustments based on the customer’s equipment and target results.